1.1 These Terms govern your use of MEDIPENCIL, a voice recording-based clinical documentation support service (the “Service”) provided by Huniverse Global Co., Ltd. (“we”, “us”, the “Provider”), through medipencil.com (the “Website”). The Service is built on the Dr.Pencil solution developed by KaiLab Co., Ltd. (the “Developer”) and licensed to us.

1.2 These Terms apply to users located outside the Republic of Korea. Users in the Republic of Korea are subject to separate terms published for that market.

1.3 The Service is intended for qualified healthcare professionals and healthcare organizations in the course of their professional activity. It is not intended for patients or for the 
general public.

1.4 Where you register on behalf of a practice, clinic, hospital or other organisation, you confirm that you have authority to bind it, and that organisation is the Customer under these Terms. The Customer is responsible for its Users’ use of the Service and for their compliance with these Terms. Where you register for your own use, you are the Customer.

1.5 Where we have entered into a separate signed written agreement with a Customer for the Service, that agreement prevails over these Terms to the extent of any conflict. In all
other respects these Terms continue to apply.

1.6 Where mandatory law in your country gives you rights greater than those set out here, those rights apply in addition and nothing in these Terms limits them.

Huniverse Global Co., Ltd.

9F, 25 Wangsan-ro, Dongdaemun-gu, Seoul, Republic of Korea

contact@medipencil.com

For the purposes of these Terms, the terms set out below have the following meanings:

Customer: individual or organisation that enters into these Terms, as determined under clause 1.4.

User: individual holding login credentials to the Service, whether the Customer or a person authorized by the Customer.

Voice Data: audio recorded by a User through the Service.

Converted Text: text produced from Voice Data by the Service.

Patient Data: personal data relating to a patient that is processed through the Service.

Subscription: recurring paid plan for the Service.

Subscription Period: billing cycle selected by the Customer, at the end of which the Subscription renews unless cancelled.

Fees: amounts payable under the Customer’s plan, including subscription and usage fees.

4.1 You must complete our registration process, provide accurate information and keep it up to date. You must be a qualified healthcare professional, or authorized by a healthcare organisation to use the Service on its behalf.

4.2 Accounts are personal to each User. You must not transfer, lend or share an account, you must keep credentials confidential, and you must maintain control of the devices used to access the Service.

4.3 Where the Customer is an organisation, it must remove a User’s access promptly when that person no longer requires it.

4.4 Notify us immediately if you become aware of unauthorized use of an account. You are responsible for losses arising from a failure to keep credentials secure, except where the loss is attributable to us.

4.5 You are responsible for having a suitable device and internet connection to use the Service.

6.1 We may amend these Terms where necessary to reflect changes in the Service, in applicable law, or in our operations. We will give at least 30 days’ notice by email and on the Website, setting out the changes and the date they take effect.

6.2 If you do not accept an amendment, you may terminate before it takes effect and we will refund Fees for the unused portion of the current Subscription Period. Continuing to use 
the Service after the effective date constitutes acceptance.

7.1 We offer free and paid plans. Features, limits and pricing may vary by country and may change in accordance with clause 7.6.

7.2 You are charged the applicable subscription or usage fees when you subscribe to a paid plan, exceed the limits of a free plan, or use paid features. Fees, the billing cycle and payment methods are displayed before you complete your purchase, and you are charged only after you have confirmed them. Subscription fees are billed in advance for each
Subscription Period. Invoices and statements are provided electronically.

7.3 Fees include applicable taxes unless otherwise stated. Where tax is not included, you are responsible for any tax due in your country.

7.4 Payment is made by credit or debit card, or by another method we make available. You authorize us to charge the payment method on file for Fees as they fall due, including on
automatic renewal, and you must keep your payment details current. Currency conversion is handled by your payment provider, and we are not responsible for conversion rates or
fees applied by your bank or card issuer.

7.5 Subscriptions renew automatically at the end of each Subscription Period unless cancelled. We will notify you of the renewal date and the amount payable at least 7 days before each renewal. You may cancel renewal at any time under clause 9.1.

7.6 We will not increase Fees, or convert a free feature into a paid one, without giving at least 30 days’ notice and obtaining your express consent. If you do not consent, your 
existing terms continue or your Subscription ends at the end of the current Subscription Period.

7.7 Unpaid Fees may result in suspension or termination under clause 16. We may charge interest on overdue amounts at the rate provided by applicable law.

8.1 We may offer a free trial. Where we do, we will tell you before you sign up how long it lasts, whether it converts to a paid Subscription, what you will be charged on conversion, and how to cancel.

8.2 Where a trial converts automatically to a paid Subscription, we will notify you of the conversion date and the amount payable before the first charge is taken. You may cancel at any time during the trial, and no Fees will be charged.

9.1 You may cancel at any time through your account settings or by emailing contact@medipencil.com. Cancellation stops future renewals and takes effect at the end
of the current Subscription Period, and you retain access until then. Fees already paid for that period are not refunded unless clause 9.2 or 9.3 applies, or unless
applicable law requires otherwise.

9.2 Where mandatory consumer law in your country gives you a right to withdraw shortly after purchase, that right applies. In the European Union, the EEA and the
United Kingdom this period is 14 days from the conclusion of the contract, or from the date of the first payment where a free trial converts to a paid Subscription. To
withdraw, email contact@medipencil.com. If you asked us to start the Service during that period, you pay a proportionate amount for what was supplied and we refund the balance to your original payment method within 14 days. This right applies once, at the start of the contract, and does not arise again on renewal.

9.3 Where the Service becomes unavailable for reasons attributable to us, where we discontinue the Service, or where you terminate under clause 5.3 or 6.2, we
refund the Fees for the unused portion in full.

9.4 Except as set out in this clause 9 or as required by applicable law, Fees are non-refundable.

9.5 You may close your account at any time through your account settings or by contacting us. Closing an account will not be made more difficult than opening one.

14.1 We implement appropriate technical and organizational measures to protect the Service and the data processed through it against unauthorized access, loss,
alteration and disclosure.

16.1 We may restrict or suspend the Service where you breach these Terms, where maintenance is required, where the Developer discontinues the solution or a
technical failure occurs, where provision is restricted by law in your country, where we need to protect you, us or our partners from fraudulent activity, or where Fees
remain unpaid after we have asked you to pay and allowed a reasonable period to do so.

16.2 We may terminate these Terms and close your account on written notice where you materially breach these Terms and do not remedy the breach within 30 days of being asked to do so, or immediately where the breach cannot be remedied or where you use the Service unlawfully or fraudulently.

16.3 We will give notice before suspending the Service, or immediately afterwards where the matter is urgent. Suspension or termination does not extinguish Fees
already accrued.

16.4 If we discontinue the Service permanently, we will give at least 30 days’ notice and refund Fees under clause 9.3. You should transfer any material you need to
your own systems before the discontinuation date.

16.5 Clauses 10, 11, 12, 13, 18 and 19 survive termination.

17.1 The Service is an administrative documentation aid. It does not constitute medical advice, diagnosis or treatment recommendations; it is not a substitute for
professional clinical judgement; and it is not intended to diagnose, treat, prevent or monitor disease. It is not a medical device.

17.2 You retain sole and final responsibility for all clinical decisions and for the accuracy of your clinical documentation. Output generated using artificial intelligence
may contain errors, omissions or fabricated content.

17.3 You must review, correct and verify all output before incorporating it into a clinical record or relying on it for any clinical purpose, exercising your independent
professional judgement.

18.1 Nothing in these Terms limits our liability for death or personal injury caused by our negligence, for fraud, or for anything else that cannot be limited under the law applicable to you.

18.2 Subject to clause 18.1, we are not liable for loss of profit, loss of business, loss of goodwill, loss or corruption of data, or any indirect or consequential loss.

18.3 Subject to clause 18.1, our total liability arising out of or in connection with these Terms is limited to the Fees you paid in the twelve months before the event giving rise to the claim. For consumers, this limit applies only to the extent permitted by the law of your country.

18.4 We are not liable for any loss arising from your use of output produced by the Service where you have not reviewed and verified it in accordance with clause 17.3.

19.1 These Terms are governed by the laws of the Republic of Korea.

19.2 If you have a complaint, contact us at contact@medipencil.com. We will acknowledge it and aim to resolve it promptly. Disputes will first be addressed by
discussion between the parties.

19.3 If a dispute cannot be resolved by agreement, it shall be finally settled by arbitration administered by the Korean Commercial Arbitration Board under its
International Arbitration Rules. The seat of the arbitration shall be Seoul, and the language of the proceedings shall be English.

19.4 Clause 19.1 does not deprive a Customer who is a consumer of the protection of mandatory provisions of the law of the country in which they are habitually
resident. Such a Customer may bring proceedings in the courts of that country, and we may bring proceedings against such a Customer only in those courts.

20.1 If any provision of these Terms is found to be invalid or unenforceable, the remaining provisions continue in full force.

20.2 Neither party is liable for a failure to perform its obligations where that failure is caused by an event beyond its reasonable control, including government action,
changes in law, industrial action, fire, flood, natural disaster, failure of telecommunications or internet infrastructure, or loss or destruction of data of significant
importance. The affected party will notify the other without undue delay.

20.3 These Terms take effect on September 14 2026, and replace any previous version.